Structural basis for phosphorylation-dependent signaling in the DNA-damage response

Biochemistry and Cell Biology

Volumn 83, Issue 6, 2005, Pages 721-727

  Williams, R Scott ^a   Bernstein, Nina ^a   Lee, Megan S ^a   Rakovszky, Melissa L ^a   Cui, Diana ^a   Green, Ruth ^a   Weinfeld, Michael ^a   Glover, J N Mark ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

BRCA1; BRCT; Breast cancer; DNA damage response; FHA; Phosphopeptide protein interactions; PNK; Polynucleotide kinase

Indexed keywords

CELLS; CYTOLOGY; ENZYME KINETICS; MOLECULAR BIOLOGY; PROTEINS; SUBSTRATES;

BRCA1; BRCT; BREAST CANCERS; DNA DAMAGE RESPONSE; FHA; PHOSPHOPEPTIDE- PROTEIN INTERACTIONS; PNK; POLYNUCLEOTIDE KINASE;

DNA;

AMINO ACID; BRCA1 PROTEIN; PHOSPHOSERINE; POLYNUCLEOTIDE 5' HYDROXYL KINASE; SERINE; THREONINE;

CARBOXY TERMINAL SEQUENCE; CELL CYCLE ARREST; CONFERENCE PAPER; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; DNA STRUCTURE; EUKARYOTIC CELL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; TANDEM REPEAT;

AMINO ACID SEQUENCE; ANIMALS; BRCA1 PROTEIN; CELL CYCLE; DNA DAMAGE; DNA REPAIR; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION;

EUKARYOTA;

EID: 32044473032     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/o05-153     Document Type: Conference Paper

References (30)

1. Bernstein, N.K., Williams, R.S., Rakovszky, M.L., Cui, D., Green, R., Karimi-Busheri, F. et al. 2005. The molecular architecture of the mammalian DNA repair enzyme, polynucleotide kinase. Mol. Cell, 17: 657-670.
2. Bork, P., Hofmann, K., Bucher, P., Neuwald, A.F., Altschul, S.F., and Koonin E.V. 1997. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. FASEB J. 11: 68-76.
3. Callebaut, I., and Mornon, J.P. 1997. From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair. FEBS Lett. 400: 25-30.
4. Cantor, S.B., Bell, D.W., Ganesan, S., Kass, E.M., Drapkin, R., Grossman, S. et al. 2001. Bach1, a novel helicase-like protein, interacts directly with brca1 and contributes to its DNA repair function. Cell. 105: 149-160.
5. Chappell, C., Hanakahi, L.A., Karimi-Busheri, F., Weinfeld, M., and West, S.C. 2002. Involvement of human polynucleotide kinase in double-strand break repair by non-homologous end joining. EMBO J. 21: 2827-2832.
6. Clapperton, J.A., Manke, I.A., Lowery, D.M., Ho, T., Haire, L.F., Yaffe, M.B., and Smerdon S.J. 2004. Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer. Nat. Struct. Mol. Biol. 11: 512-518.
7. Clements, P.M., Breslin, C., Deeks, E.D., Byrd, P.J., Ju, L., Bieganowski, P. et al. 2004. The ataxia-oculomotor apraxia 1 gene product has a role distinct from ATM and interacts with the DNA strand break repair proteins XRCC1 and XRCC4. DNA Repair (Amsterdam), 3: 1493-1502.
8. Durocher, D., and Jackson, S.P. 2002. The FHA domain. FEBS Lett. 513: 58-66.
9. Durocher, D., Taylor, I.A., Sarbassova, D., Haire, L.F., Westcott, S.L., Jackson, S.P. et al. 2000. The molecular basis of FHA domain: phosphopeptide binding specificity and implications for phospho-dependent signaling mechanisms. Mol. Cell. 6: 1169-1182.
10. Futreal, P.A., Liu, Q., Shattuck-Eidens, D., Cochran, C., Harshman, K., Tavtigian, S. et al. 1994. BRCA1 mutations in primary breast and ovarian carcinomas. Science (Washington, D.C.), 266: 120-122.
11. Glover, J.N., Williams, R.S., and Lee, M.S. 2004. Interactions between BRCT repeats and phosphoproteins: tangled up in two. Trends Biochem. Sci. 29: 579-585.
12. Gueven, N., Becherel, O.J., Kijas, A.W., Chen, P., Howe, O., Rudolph, J.H. et al. 2004. Aprataxin, a novel protein that protects against genotoxic stress. Hum. Mol. Genet. 13: 1081-1093.
13. Koch, C.A., Agyei, R., Galicia, S., Metalnikov, P., O'Donnell, P., Starostine, A. et al. 2004. Xrcc4 physically links DNA end processing by polynucleotide kinase to DNA ligation by DNA ligase IV. EMBO J. 23: 3874-3885.
14. Koonin, E.V., Altschul, S.F., and Bork, P. 1996. BRCA1 protein products...Functional motifs... Nat. Genet. 13: 266-268.
15. Li, J., Williams, B.L., Haire, L.F., Goldberg, M., Wilker, E., Durocher, D. et al. 2002. Structural and functional versatility of the FHA domain in DNA-damage signaling by the tumor suppressor kinase Chk2. Mol. Cell. 9: 1045-1054.
16. Loizou, J.I., El-Khamisy, S.F., Zlatanou, A., Moore, D.J., Chan, D.W., Qin, J. et al. 2004. The protein kinase CK2 facilitates repair of chromosomal DNA single-strand breaks. Cell, 117: 17-28.
17. Luo, H., Chan, D.W., Yang, T., Rodriguez, M., Chen, B.P., Leng, M. et al. 2004. A new XRCC1-containing complex and its role in cellular survival of methyl methanesulfonate treatment. Mol. Cell. Biol. 24: 8356-8365.
18. Manke, I.A., Lowery, D.M., Nguyen, A., and Yaffe, M.B. 2003. BRCT repeats as phosphopeptide-binding modules involved in protein targeting. Science (Washington, D.C.). 302: 636-639.
19. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P.A., Harshman, K., Tavtigian, S. et al. 1994. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science (Washington, D.C.), 266: 66-71.
20. Moreira, M.C., Barbot, C., Tachi, N., Kozuka, N., Uchida, E., Gibson, T. et al. 2001. The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin. Nat. Genet. 29: 189-193.
21. Rasouli-Nia, A., Karimi-Busheri, F., and Weinfeld, M. 2004. Stable down-regulation of human polynucleotide kinase enhances spontaneous mutation frequency and sensitizes cells to genotoxic agents. Proc. Natl. Acad. Sci. U.S.A. 101: 6905-6910.
22. Rodriguez, M., Yu, X., Chen, J., and Songyang, Z. 2003. Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains. J. Biol. Chem. 278: 52914-52918.
23. Shiozaki, E.N., Gu, L., Yan, N., and Shi, Y. 2004. Structure of the BRCT repeats of BRCA1 bound to a BACH1 phosphopeptide: implications for signaling. Mol. Cell, 14: 405-412.
24. Williams, R.S., Chasman, D.I., Hau, D.D., Hui, B., Lau, A.Y., and Glover, J.N. 2003. Detection of protein folding defects caused by BRCA1-BRCT truncation and missense mutations. J. Biol. Chem. 278: 53007-53016.
25. Williams, R.S., and Glover, J.N. 2003. Structural consequences of a cancer-causing BRCA1-BRCT missense mutation. J. Biol. Chem. 278: 2630-2635.
26. Williams, R.S., Green, R., and Glover, J.N. 2001. Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1. Nat. Struct. Biol. 8: 838-842.
27. Williams, R.S., Lee, M.S., Hau, D.D., and Glover, J.N. 2004. Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1. Nat. Struct. Mol. Biol. 11: 519-525.
28. Yaffe, M.B., and Smerdon, S.J. 2001. PhosphoSerine/threonine binding domains: you can't pSERious? Structure (Cambridge), 9: R33-R38.
29. Yu, X., and Chen, J. 2004. DNA damage-induced cell cycle checkpoint control requires CtIP, a phosphorylation-dependent binding partner of BRCA1 C-terminal domains. Mol. Cell. Biol. 24: 9478-9486.
30. Yu, X., Chini, C.C., He, M., Mer, G., and Chen, J. 2003. The BRCT domain is a phospho-protein binding domain. Science (Washington, D.C.), 302: 639-642.